Joseph M. Rocco

556 total citations
30 papers, 236 citations indexed

About

Joseph M. Rocco is a scholar working on Infectious Diseases, Hematology and Immunology. According to data from OpenAlex, Joseph M. Rocco has authored 30 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 9 papers in Hematology and 9 papers in Immunology. Recurrent topics in Joseph M. Rocco's work include Autoimmune and Inflammatory Disorders Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and Immune Cell Function and Interaction (5 papers). Joseph M. Rocco is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and Immune Cell Function and Interaction (5 papers). Joseph M. Rocco collaborates with scholars based in United States, United Kingdom and New Zealand. Joseph M. Rocco's co-authors include Irini Sereti, Maura Manion, Elizabeth Laidlaw, Adam Rupert, Andrea Lisco, Silvia Lucena Lage, Glenn Wortmann, Rita Poon, Princy Kumar and Anela Kellogg and has published in prestigious journals such as Blood, The Journal of Immunology and Gastroenterology.

In The Last Decade

Joseph M. Rocco

26 papers receiving 234 citations

Peers

Countries citing papers authored by Joseph M. Rocco

Since Specialization

Citations

This map shows the geographic impact of Joseph M. Rocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph M. Rocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph M. Rocco more than expected).

Fields of papers citing papers by Joseph M. Rocco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph M. Rocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph M. Rocco. The network helps show where Joseph M. Rocco may publish in the future.

Co-authorship network of co-authors of Joseph M. Rocco

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph M. Rocco. A scholar is included among the top collaborators of Joseph M. Rocco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph M. Rocco. Joseph M. Rocco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy 2025 ·Haematologica ·Lauren K. Meyer, Jerry C. Lee, Joseph M. Rocco, Kim E. Nichols	1
2	Babesiosis with low parasitemia as a cause of secondary hemophagocytic lymphohistiocytosis in a previously healthy adult 2025 ·IDCases ·(unknown), Joseph M. Rocco, Lis Smedegaard Andersen, Thomas Robertson	1
3	Pre-infusion risk factors predict severe infectious complications of CAR T-cell therapy in pediatric and adult patients with B-ALL 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Yannis K. Valtis, (unknown), Surabhi B Vora, Joseph M. Rocco, Véronique Nussenblatt, Sara Silbert, Haneen Shalabi, Bonnie Yates, Jae H. Park, Adam J. Lamble, Kai Rejeski, Nirali N. Shah	0
4	Proliferation of a Novel CD3neg Hyperactivated T-Cell Population Characterizes Adult Hemophagocytic Lymphohistiocytosis and Associates with Disease Activity 2024 ·Blood ·Joseph M. Rocco, Elizabeth Laidlaw, Bonnie Yates, Brett Schroeder, (unknown), W. Thomas Johnson, Joseph H. Oved, (unknown), W. H. Ewing, Courtney D. Fitzhugh, Maura Manion, (unknown), Steven M. Holland, Nirali N. Shah, Irini Sereti	1
5	Perplexing paradoxical reactions: navigating the complexity of protracted tuberculosis meningitis—a case report 2024 ·Frontiers in Immunology ·(unknown), Dima A. Hammoud, (unknown), Joseph M. Rocco, Elizabeth Laidlaw, Safia Kuriakose, (unknown), (unknown), Valentino J. Stella, (unknown), (unknown), (unknown), Maunank Shah, Joseph L. Malone, Adam Rupert, Irini Sereti, Maura Manion	3
6	Clonal hematopoiesis in people with advanced HIV and associated inflammatory syndromes 2024 ·JCI Insight ·Joseph M. Rocco, Yifan Zhou, (unknown), Elizabeth Laidlaw, (unknown), Megan Anderson, Adam Rupert, Silvia Lucena Lage, Ana M. Ortega‐Villa, Shiqin Yu, Andrea Lisco, Maura Manion, George S. Vassiliou, Cynthia E. Dunbar, Irini Sereti	3
7	Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients 2024 ·Frontiers in Immunology ·Ainhoa Pérez‐Díez, Xiangdong Liu, (unknown), (unknown), Andrea Lisco, (unknown), (unknown), Matthew J. Memoli, Joseph M. Rocco, (unknown), Elizabeth Laidlaw, (unknown), Maura Manion, Glenn Wortmann, Rita Poon, Princy Kumar, Irini Sereti	0
8	Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases 2024 ·Blood ·Silvia Lucena Lage, Ramya Ramaswami, Joseph M. Rocco, Adam Rupert, David A. Davis, Kathryn Lurain, Maura Manion, Denise Whitby, Robert Yarchoan, Irini Sereti	10
9	The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19 2024 ·Seminars in Hematology ·(unknown), Joseph M. Rocco, Véronique Nussenblatt	1
10	Prevalence and complement activation of anti-lymphocyte IgM antibodies in hospitalized COVID-19 patients 2023 ·The Journal of Immunology ·Ainhoa Pérez‐Díez, Xiangdong Liu, (unknown), (unknown), Andrea Lisco, (unknown), (unknown), Matthew J. Memoli, Joseph M. Rocco, Elizabeth Laidlaw, Michael C. Sneller, Maura Manion, Irini Sereti	1
11	Mycobacterial Immune Reconstitution Inflammatory Syndrome in HIV is Associated With Protein-Altering Variants in Hemophagocytic Lymphohistiocytosis-Related Genes 2023 ·The Journal of Infectious Diseases ·Joseph M. Rocco, Elizabeth Laidlaw, (unknown), (unknown), Ornella Sortino, Safia Kuriakose, (unknown), Maura Manion, Irini Sereti	9
12	Long-term Outcomes of Patients With HIV and Pneumocystis jirovecii Pneumonia in the Antiretroviral Therapy Era 2023 ·Open Forum Infectious Diseases ·(unknown), Maura Manion, Arlene Sirajuddin, Elizabeth Laidlaw, (unknown), Megan Anderson, Gregg Roby, Joseph M. Rocco, Andrea Lisco, Virginia Sheikh, Joseph A. Kovacs, Irini Sereti	5
13	Free interleukin-18 is elevated in CD22 CAR T-cell–associated hemophagocytic lymphohistiocytosis–like toxicities 2023 ·Blood Advances ·Joseph M. Rocco, Jon R. Inglefield, Bonnie Yates, Daniel A. Lichtenstein, Yanyu Wang, Laurence Goffin, (unknown), Eduardo J. Schiffrin, Nirali N. Shah	15
14	A Gut Feeling: Inflammatory Disease Revealed During Immune Reconstitution 2023 ·Gastroenterology ·Joseph M. Rocco, Aaron Richterman, Irini Sereti	0
15	Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia 2023 ·Journal of Allergy and Clinical Immunology ·Joseph M. Rocco, Kristin L. Boswell, Elizabeth Laidlaw, (unknown), Megan Anderson, Leonid Serebryannyy, Sandeep Narpala, Sarah O’Connell, Heather Kalish, (unknown), (unknown), Cihan Oguz, Adrian B. McDermott, Maura Manion, Richard A. Koup, Andrea Lisco, Irini Sereti	2
16	Proinflammatory TH17 cytokine activation, disease severity and outcomes in peripartum cardiomyopathy 2021 ·International Journal of Cardiology ·(unknown), (unknown), Joseph M. Rocco, Gregory A. Ewald, Michael M. Givertz, Navin Rajagopalan, Biykem Bozkurt, Uri Elkayam, Leslie T. Cooper, James D. Fett, Charles F. McTiernan, Penelope A. Morel, Karen Hanley‐Yanez, Dennis M. McNamara	4
17	Trismus and voice change after starting tuberculosis treatment 2021 ·IDCases ·Joseph M. Rocco, Dima A. Hammoud, Clint Allen, (unknown), Elizabeth Laidlaw, Irini Sereti	0
18	Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies 2021 ·Journal of Translational Autoimmunity ·Joseph M. Rocco, (unknown), (unknown), (unknown), Samantha Kreuzburg, Steven M. Holland, Christa S. Zerbe	7
19	Severe anaplasmosis represents a treatable cause of secondary hemophagocytic lymphohistiocytosis: Two cases and review of literature 2020 ·Ticks and Tick-borne Diseases ·Joseph M. Rocco, (unknown), Dustin McCurry, Neel Shah	11
20	Higher Prevalence of Babesia microti than Borrelia burgdorferi in Small Mammal Species in Central Pennsylvania, United States 2019 ·Vector-Borne and Zoonotic Diseases ·Joseph M. Rocco, (unknown), Jeffery L. Larkin, (unknown), (unknown), Paul M. Nealen, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact